These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 25432628)

  • 1. Boosting Wnt activity during colorectal cancer progression through selective hypermethylation of Wnt signaling antagonists.
    Silva AL; Dawson SN; Arends MJ; Guttula K; Hall N; Cameron EA; Huang TH; Brenton JD; Tavaré S; Bienz M; Ibrahim AE
    BMC Cancer; 2014 Nov; 14():891. PubMed ID: 25432628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concurrent Hypermethylation of
    Wang H; Duan XL; Qi XL; Meng L; Xu YS; Wu T; Dai PG
    Mol Cells; 2017 Jan; 40(1):45-53. PubMed ID: 28152305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant DNA methylation of WNT pathway genes in the development and progression of CIMP-negative colorectal cancer.
    Galamb O; Kalmár A; Péterfia B; Csabai I; Bodor A; Ribli D; Krenács T; Patai ÁV; Wichmann B; Barták BK; Tóth K; Valcz G; Spisák S; Tulassay Z; Molnár B
    Epigenetics; 2016 Aug; 11(8):588-602. PubMed ID: 27245242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA methylation of SFRP1, SFRP2, and WIF1 and prognosis of postoperative colorectal cancer patients.
    Liu X; Fu J; Bi H; Ge A; Xia T; Liu Y; Sun H; Li D; Zhao Y
    BMC Cancer; 2019 Dec; 19(1):1212. PubMed ID: 31830937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter methylation of Wnt-antagonists in polypoid and nonpolypoid colorectal adenomas.
    Voorham QJ; Janssen J; Tijssen M; Snellenberg S; Mongera S; van Grieken NC; Grabsch H; Kliment M; Rembacken BJ; Mulder CJ; van Engeland M; Meijer GA; Steenbergen RD; Carvalho B
    BMC Cancer; 2013 Dec; 13():603. PubMed ID: 24350795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypermethylation and expression regulation of secreted frizzled-related protein genes in colorectal tumor.
    Qi J; Zhu YQ; Luo J; Tao WH
    World J Gastroenterol; 2006 Nov; 12(44):7113-7. PubMed ID: 17131472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic regulation of WNT signaling pathway genes in inflammatory bowel disease (IBD) associated neoplasia.
    Dhir M; Montgomery EA; Glöckner SC; Schuebel KE; Hooker CM; Herman JG; Baylin SB; Gearhart SL; Ahuja N
    J Gastrointest Surg; 2008 Oct; 12(10):1745-53. PubMed ID: 18716850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic silencing of sFRP1 activates the canonical Wnt pathway and contributes to increased cell growth and proliferation in hepatocellular carcinoma.
    Kaur P; Mani S; Cros MP; Scoazec JY; Chemin I; Hainaut P; Herceg Z
    Tumour Biol; 2012 Apr; 33(2):325-36. PubMed ID: 22351518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
    Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
    World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoter methylation of Wnt antagonists DKK1 and SFRP1 is associated with opposing tumor subtypes in two large populations of colorectal cancer patients.
    Rawson JB; Manno M; Mrkonjic M; Daftary D; Dicks E; Buchanan DD; Younghusband HB; Parfrey PS; Young JP; Pollett A; Green RC; Gallinger S; McLaughlin JR; Knight JA; Bapat B
    Carcinogenesis; 2011 May; 32(5):741-7. PubMed ID: 21304055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer.
    Aguilera O; Fraga MF; Ballestar E; Paz MF; Herranz M; Espada J; García JM; Muñoz A; Esteller M; González-Sancho JM
    Oncogene; 2006 Jul; 25(29):4116-21. PubMed ID: 16491118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Wnt antagonists DKK1 and SFRP1 are downregulated by promoter hypermethylation in systemic sclerosis.
    Dees C; Schlottmann I; Funke R; Distler A; Palumbo-Zerr K; Zerr P; Lin NY; Beyer C; Distler O; Schett G; Distler JH
    Ann Rheum Dis; 2014 Jun; 73(6):1232-9. PubMed ID: 23698475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA hypermethylation and decreased mRNA expression of MAL, PRIMA1, PTGDR and SFRP1 in colorectal adenoma and cancer.
    Kalmár A; Péterfia B; Hollósi P; Galamb O; Spisák S; Wichmann B; Bodor A; Tóth K; Patai ÁV; Valcz G; Nagy ZB; Kubák V; Tulassay Z; Kovalszky I; Molnár B
    BMC Cancer; 2015 Oct; 15():736. PubMed ID: 26482433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.
    Kim JH; Bae JM; Cho NY; Kang GH
    Oncotarget; 2016 Mar; 7(12):14095-111. PubMed ID: 26883113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic silencing of SFRP1 and SFRP5 by hepatitis B virus X protein enhances hepatoma cell tumorigenicity through Wnt signaling pathway.
    Xie Q; Chen L; Shan X; Shan X; Tang J; Zhou F; Chen Q; Quan H; Nie D; Zhang W; Huang AL; Tang N
    Int J Cancer; 2014 Aug; 135(3):635-46. PubMed ID: 24374650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypermethylation of multiple Wnt antagonist genes in gastric neoplasia: Is H pylori infection blasting fuse?
    Wang Z; Ye Y; Liu D; Yang X; Wang F
    Medicine (Baltimore); 2018 Dec; 97(52):e13734. PubMed ID: 30593147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the DNA methylation level of cancer-related genes in colorectal cancer and the surrounding normal mucosa.
    Sugai T; Yoshida M; Eizuka M; Uesugii N; Habano W; Otsuka K; Sasaki A; Yamamoto E; Matsumoto T; Suzuki H
    Clin Epigenetics; 2017; 9():55. PubMed ID: 28533824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points.
    O'Brien MJ; Yang S; Mack C; Xu H; Huang CS; Mulcahy E; Amorosino M; Farraye FA
    Am J Surg Pathol; 2006 Dec; 30(12):1491-501. PubMed ID: 17122504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dickkopf-Related Protein 2 is Epigenetically Inactivated and Suppresses Colorectal Cancer Growth and Tumor Metastasis by Antagonizing Wnt/β-Catenin Signaling.
    Wang C; Yue Y; Shao B; Qiu Z; Mu J; Tang J; Han X; Xiang T; Ren G
    Cell Physiol Biochem; 2017; 41(5):1709-1724. PubMed ID: 28365691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Wnt antagonist sFRP1 in colorectal tumorigenesis.
    Caldwell GM; Jones C; Gensberg K; Jan S; Hardy RG; Byrd P; Chughtai S; Wallis Y; Matthews GM; Morton DG
    Cancer Res; 2004 Feb; 64(3):883-8. PubMed ID: 14871816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.